187 related articles for article (PubMed ID: 15894495)
1. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
[TBL] [Abstract][Full Text] [Related]
4. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
5. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
[TBL] [Abstract][Full Text] [Related]
7. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
[TBL] [Abstract][Full Text] [Related]
8. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S
Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.
Boige V; Castéra L; de Roux N; Ganne-Carrié N; Ducot B; Pelletier G; Beaugrand M; Buffet C
Gut; 2003 Aug; 52(8):1178-81. PubMed ID: 12865278
[TBL] [Abstract][Full Text] [Related]
11. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
Natarajan Y; Patel P; Chu J; Yu X; Hernaez R; El-Serag H; Kanwal F
Dig Dis Sci; 2023 Jan; 68(1):312-322. PubMed ID: 35790703
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
[TBL] [Abstract][Full Text] [Related]
13. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
15. Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.
Ezzikouri S; Rebbani K; Mostafa A; El Feydi AE; Afifi R; Brahim I; Kitab B; Benazzouz M; Kandil M; Nadifi S; Pineau P; Benjelloun S
J Med Virol; 2011 Dec; 83(12):2096-102. PubMed ID: 22012716
[TBL] [Abstract][Full Text] [Related]
16. [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma].
Ropero P; Briceño O; López-Alonso G; Agúndez JA; González Fernández FA; García-Hoz F; Villegas Martínez A; Díaz-Rubio M; Ladero JM
Rev Esp Enferm Dig; 2007 Jul; 99(7):376-81. PubMed ID: 17973580
[TBL] [Abstract][Full Text] [Related]
17. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.
Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M
Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis.
Tomatsu S; Orii KO; Fleming RE; Holden CC; Waheed A; Britton RS; Gutierrez MA; Velez-Castrillon S; Bacon BR; Sly WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15788-93. PubMed ID: 14673107
[TBL] [Abstract][Full Text] [Related]
20. HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.
Sikorska K; Bielawski KP; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Romanowski T
Int J Mol Med; 2005 Dec; 16(6):1151-6. PubMed ID: 16273299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]